Theriva Biologics's total assets for Q3 2025 were $30.84M, a decrease of -13.94% from the previous quarter. TOVX total liabilities were $24.10M for the fiscal quarter, a -4.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.